Summary
For Year 2026-27, Vilin Bio Med reports the following shareholding: Total Promoters at 63.65%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 36.35%. This breakdown provides a quick snapshot of ownership distribution for Vilin Bio Med in 2026-27.
Vilin Bio Med FAQs
As of 04-2026, the promoter shareholding in Vilin Bio Med stands at 63.65% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Vilin Bio Med is 0% and 0% respectively.
The retail shareholding of the Vilin Bio Med is 36.35%.
Changes in shareholding patterns of Vilin Bio Med can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Vilin Bio Med are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
